<DOC>
	<DOCNO>NCT01739803</DOCNO>
	<brief_summary>There critical gap knowledge implement effective intervention renal transplant recipient ( RTRs ) improve immunosuppressant therapy ( IST ) adherence clinical outcome . The objective project address gap : ( 1 ) designing , implement , evaluate patient-specific behavioral contract intervention improve RTRs ' IST adherence rate ( contract write , sign agreement RTR healthcare provider RTR agree adherent IST accord mutually agree upon criterion ) ; ( 2 ) measuring effect IST adherence RTRs ' health-related quality life ( HQoL ) healthcare utilization cost . The primary hypothesis one year post trial enrollment , RTRs establish behavioral contract healthcare professional adherent establish behavioral contract subsequently great HQoL low healthcare utilization cost . Once well understood implement effective IST adherence intervention program , clinician valuable tool promote therapeutic success , improve HQoL , reduce healthcare utilization cost . Therefore , pursue follow Specific Aims : ( 1 ) determine effectiveness IST adherence contract-based intervention IST adherence ; ( 2 ) determine relationship IST adherence , intervention , RTRs ' HQoL ; ( 3 ) determine influence IST adherence intervention RTRs ' healthcare utilizations/costs . To achieve Specific Aims , randomize control trial patient-specific behavioral contract-based intervention conduct , data regard adherence , HQoL , healthcare utilizations/costs collect 12-month period RTR study participant analyze . This project promote healthy life , increase well-being , reduce burden illness disparity among adult RTRs provide data regard adherence intervention impact IST adherence behavioral contract intervention RTRs ' health economic outcome HQoL . Collectively , new knowledge provide critical step toward optimize RTRs ' graft maintenance , productivity , HQoL , decrease graft rejection , return dialysis , morbidity , mortality , healthcare cost .</brief_summary>
	<brief_title>Behavioral Contract Adherence Intervention</brief_title>
	<detailed_description />
	<criteria>renal transplant recipient least 21 year age receive immunosuppressant regimen contain oral cyclosporine tacrolimus least one year posttransplant obtain immunosuppressant therapy Avella Specialty Pharmacy least one year prior study enrollment study period pregnant prisoner institutionalize unable give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Immunosuppressant therapy adherence</keyword>
	<keyword>Quality life</keyword>
	<keyword>Economic outcome</keyword>
</DOC>